Latest News

Date Title Topic
28 Jan 2016 FDA Extends Indications for Ofatumumab in CLL Haematologic malignancies - Anticancer agents & Biologic therapy
27 Jan 2016 Nivolumab plus Ipilimumab Regimen Receives Expanded FDA Approval in Unresectable or Metastatic Melanoma Across BRAF Status Melanoma - Cancer Immunology and Immunotherapy
27 Jan 2016 Annals of Oncology Press Release: Important falls in death rates from leukaemia in Europe predicted for 2016 Haematologic malignancies
Cervical Cancer
22 Jan 2016 NEW for 2016! European Integration Fellowship
19 Jan 2016 ESMO Workshop: Cancer Patient Advocacy Networks Driving Research
Pre-IMPAKT 2016 Training Course
12 Jan 2016 January 2016 – Image of the Month
11 Jan 2016 ESMO-ESO Course on Medical Oncology for Medical Students 2016
07 Jan 2016 New NICE Guidelines to Improve End of Life Care Palliative and supportive care
04 Jan 2016 ESMO E-Learning: Breast Cancer in Young Women
04 Jan 2016 Colorectal Cancer in Young Adults: the Focus on Hereditary Cancer Syndromes
21 Dec 2015 European Medicines Agency Recommends Two New Indications for Ramucirumab Lung and other thoracic tumours - Gastrointestinal cancers - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends Granting a Conditional Marketing Authorisation for Osimertinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Necitumumab Lung and other thoracic tumours - Anticancer agents & Biologic therapy